Atomoxetine and spironolactone combine to reduce obstructive sleep apnea (OSA) severity and blood pressure (BP) in hypertensive patients. - Milan 2023

Basic and clinical science in sleep breathing disorders: a bidirectional relationship

Chair(s): Anne Briancon-Marjollet, Candelaria Caballero Eraso

Session type: Poster session

Atomoxetine and spironolactone combine to reduce obstructive sleep apnea (OSA) severity and blood pressure (BP) in hypertensive patients.

Alan R. Schwartz

EVENTS HOME

Abstract

Previous presentation

Next presentation

Session content

Measuring value of telemonitoring in obstructive sleep apnea patient pathway optimization in hospital: a Spanish example

Sara Correia Pinto

Poster

Abstract

Impact of nocturnal hypoxemia on systemic inflammation in obstructive sleep apnea hypopnea syndrome (OSAS)

Samira Mhamdi

Poster

Abstract

Late Breaking Abstract - Detecting sleep apnea in advance using machine learning and ECG-deprived spectrogram during CPAP titration

Thanh Duy Linh Tran

Poster

Abstract

Late Breaking Abstract - In-Home Smartphone-Based Prediction of Obstructive Sleep Apnea: A Validation Study with Level 2 Polysomnography

Jeong-whun Kim

Poster

Abstract

Comparing right ventricular function in patients with severe Obstructive Sleep Apnea when treated and not treated with Continuous Positive Airway Pressure

Ahmed Dhia El Euch

Poster

Abstract

Obstructive sleep apnea and falls in COPD patients: a cross-sectional and follow-up study

Caroline Maschio De Censo

Poster

Abstract

Atomoxetine and spironolactone combine to reduce obstructive sleep apnea (OSA) severity and blood pressure (BP) in hypertensive patients.

Alan R. Schwartz

Abstract

Is CPAP pressure titration always necessary?

Qishan Wei

Poster

Abstract

RNA expression in cord blood. Can obstructive sleep apnea (OSA) during pregnancy have any effect on fetal development?

Laura Canaves

Poster

Abstract

Treatment of OSA initiating with CPAP at 10 cmH2O

Abstract

Peri-Operative Outcomes of Bariatric Surgery in Obstructive Sleep Apnoea: a Single-Centre Cohort Study

Cristiano Van Zeller

Poster

Abstract

PD-L1+ small extracellular vesicles in obstructive sleep apnea syndrome

Wojciech Trzepizur

Poster

Abstract

Association of physical activity and BMI on sleep disordered breathing and sleep related symptoms.

Ronas Shakya

Poster

Abstract

Hypoxic burden to guide CPAP treatment allocation in OSA: findings from the ISAACC trial

Lucia Pinilla

Poster

Abstract

Effects of CPAP therapy on molecular breath pattern in newly diagnosed OSA

Jonas Herth

Poster

Abstract

Central sleep apnea treated by a constant low dose of CO2 supplied by a novel device

Yuanming Luo

Poster

Abstract

Application of intermittent hypoxia to precisely-cut tissue slices: a novel ex vivo model for studying the parenchymal effects of obstructive sleep apnea (OSA)

Isaac Almendros

Poster

Abstract

Effects of adaptive servo-ventilation on quality of life and symptoms according to its treatment indication a subgroup analysis from the read-asv registry

Oliver Munt

Poster

Abstract

The link between the sphingolipid rheostat and obstructive sleep apnea

Peter Horvath

Poster

Abstract

Late Breaking Abstract - Differences in morbidity and mortality between patients with heart failure and either obstructive or central sleep apnea

Christian Horvath

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}